Anjana Das K

National Institute of Pharmaceutical Education and Research Guwahati, India

Poster(s):

• (A-256) Identifying Potential Drug Triggers for Bullous Pemphigoid: A Disproportionality Analysis of the FDA Adverse Event Reporting System and Review of Case Reports
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-246) Safety of Immune Checkpoint Inhibitors: A Systematic Review of Disproportionality Analysis Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-226) Target Fishing and Drug Repurposing for Esophageal Adenocarcinoma: An Integrated Bioinformatic and Pharmacovigilance Approach
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET